WUH: A phase 3 long term open-label trial investigating safety and efficacy of Transcon hGH administered once weekly in children with growth hormone deficiency (GHD) who have completed a prior Transcon hGH trial.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
